Fingerprint
Dive into the research topics of 'Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically